Economic Atlas
WORKSPACE
OverviewScreenerWatchlistChatAccount
EXPLORE
CompaniesPlacesPlace screenerMethodology
Terms·Privacy
Economic Atlas
HomeScreenerChatCompanies
Economic Atlas
WORKSPACE
OverviewScreenerWatchlistChatAccount
EXPLORE
CompaniesPlacesPlace screenerMethodology
Terms·Privacy
Economic Atlas
Companies/Arno Therapeutics, Inc.
Company profile

Arno Therapeutics, Inc.

OTC: ARNI · Healthcare · Biotechnology
PublicHQ Flemington, NJ · HunterdonReports USD
#1143 of 1,394 Healthcare companies by revenue
EA Score
——
FH —DQ —GM —SS 31
v0.1 · 5/100 weight · pillars only
↑ listing tenure, disclosure history · ↓ return on assets, balance-sheet leverage
Methodology →
Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$11.5M
Employees
4
Market cap
$4.9k
OverviewFinancialsSegmentsFilingsESGPeople & Places

Financials — latest annual

SEC EDGAR · USD-normalized
ConceptUSDNativeFY
Revenue$0$02015
Net income-$11.5M-$11.5M2015
Operating income-$13.4M-$13.4M2015
Total assets$361.2k$361.2k2015
Liabilities$9.0M$9.0M2015
Equity-$8.6M-$8.6M2015

Revenue trend

FY2008 – FY2015 · USD
$0
FY08
$0
FY09
$0
FY10
$0
FY11
$0
FY12
$0
FY13
$0
FY14
$0
FY15

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Arno Therapeutics, Inc. booked $0 in FY2015 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.

Peers · Healthcare
Isodiol International Inc.——Rising Biosciences, Inc.——Caliber Imaging & Diagnostics, Inc.——Sentry Petroleum Ltd——
Neighbors
Hunterdon →
Celldex Therapeutics, Inc.$1.5M58CUnity Bancorp, Inc.——
Key facts
CEODavid M. Tanen
SectorHealthcare
IndustryBiotechnology
HeadquartersFlemington, NJ
ExchangeOTC: ARNI
Employees4
IPO date2008-06-11
Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.
HomeScreenerChatCompanies